Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Tyler Reinsch"'
Publikováno v:
Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation. 7:38-48
Background: Population-based risk assessments are needed to identify individuals who may benefit from chronic obstructive pulmonary disease (COPD) management programs for preventing exacerbations. This study compared the validated COPD treatment rati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13c8051e8a708f8969de140289e46548
https://doi.org/10.15326/jcopdf.7.1.2019.0132
https://doi.org/10.15326/jcopdf.7.1.2019.0132
Publikováno v:
Respiratory medicine. 150
Use of inhaled corticosteroids and long acting beta agonist (ICS/LABA) combination therapy has been shown to decrease the frequency of exacerbations in patients with chronic obstructive pulmonary disease (COPD). In this population, adherence to treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9384904787bdb5fef00abb2ff73aad1f
https://pubmed.ncbi.nlm.nih.gov/30961933
https://pubmed.ncbi.nlm.nih.gov/30961933
Publikováno v:
Respiratory medicine. 145
Background It is unknown whether there is a benefit to initiating triple therapy (TT; inhaled corticosteroids combined with long-acting β2-agonists and long-acting muscarinic antagonists) promptly (within 30 days) following a chronic obstructive pul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81e7bac107470009852d7435e7eb8dd5
https://pubmed.ncbi.nlm.nih.gov/30509702
https://pubmed.ncbi.nlm.nih.gov/30509702
Autor:
Richard H. Stanford, Erin M Hulbert, Tyler Reinsch, Michael Hull, Ami R Buikema, Michael Bogart
Publikováno v:
Respiratory medicine. 142
Background This study assessed patient-level characteristics and patterns of medication use in patients with chronic obstructive pulmonary disease (COPD) before initiation of multiple inhaler triple therapy (MITT; long-acting muscarinic antagonist/lo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::332a175cf1ba8e83f0dc5cdb1396930a
https://pubmed.ncbi.nlm.nih.gov/30170806
https://pubmed.ncbi.nlm.nih.gov/30170806
Autor:
Richard H. Stanford, C.M. Averell, Emily D. Parker, Ami R Buikema, Tyler Reinsch, Cori Blauer-Peterson
Publikováno v:
The Journal of Allergy and Clinical Immunology: In Practice. 7:1488-1496.e7
Although efficacy and safety of fluticasone furoate/vilanterol (FF/VI) and budesonide/formoterol (BUD/F) have been demonstrated in clinical studies, real-world comparisons of utilization have not been performed.To compare similar patients with asthma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b9b3e3fd5b555f190381a1221bee39e
https://doi.org/10.1016/j.jaip.2018.12.021
https://doi.org/10.1016/j.jaip.2018.12.021